FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082181797> ?p ?o ?g. }

• W3082181797 endingPage "108" @default.
• W3082181797 startingPage "95" @default.
• W3082181797 abstract "Abstract Purpose We recently developed a chelating platform based on the macrocycle 1,4,7-triazacyclononane with up to three five-membered azaheterocyclic arms for the preparation of 68 Ga- and 64 Cu-based radiopharmaceuticals. Based on this platform, the chelator scaffold NOTI-TVA with three additional carboxylic acid groups for bioconjugation was synthesized and characterized. The primary aims of this proof-of-concept study were (1) to evaluate if trimeric radiotracers on the basis of the NOTI-TVA 6 scaffold can be developed, (2) to determine if the additional substituents for bioconjugation at the non-coordinating NH atoms of the imidazole residues of the building block NOTI influence the metal binding properties, and (3) what influence multiple targeting vectors have on the biological performance of the radiotracer. The cyclic RGDfK peptide that specifically binds to the α v ß 3 integrin receptor was selected as the biological model system. Procedures Two different synthetic routes for the preparation of NOTI-TVA 6 were explored. Three c(RGDfK) peptide residues were conjugated to the NOTI-TVA 6 building block by standard peptide chemistry providing the trimeric bioconjugate NOTI-TVA-c(RGDfK) 3 9 . Labeling of 9 with [ 64 Cu]CuCl 2 was performed manually at pH 8.2 at ambient temperature. Binding affinities of Cu- 8 , the Cu 2+ complex of the previously described monomer NODIA-Me-c(RGDfK) 8 , and the trimer Cu- 9 to integrin α v ß 3 were determined in competitive cell binding experiments in the U-87MG cell line. The pharmacokinetics of both 64 Cu-labeled conjugates [ 64 Cu]Cu- 8 and [ 64 Cu]Cu- 9 were determined by small-animal PET imaging and ex vivo biodistribution studies in mice bearing U-87MG xenografts. Results Depending on the synthetic route, NOTI-TVA 6 was obtained with an overall yield up to 58 %. The bioconjugate 9 was prepared in 41 % yield. Both conjugates [ 64 Cu]Cu- 8 and [ 64 Cu]Cu- 9 were radiolabeled quantitatively at ambient temperature in high molar activities of A m ~ 20 MBq nmol −1 in less than 5 min. Competitive inhibitory constants IC 50 of c(RDGfK) 7 , Cu- 8 , and Cu- 9 were determined to be 159.5 ± 1.3 nM, 256.1 ± 2.1 nM, and 99.5 ± 1.1 nM, respectively. In small-animal experiments, both radiotracers specifically delineated α v ß 3 integrin-positive U-87MG tumors with low uptake in non-target organs and rapid blood clearance. The trimer [ 64 Cu]Cu- 9 showed a ~ 2.5-fold higher tumor uptake compared with the monomer [ 64 Cu]Cu- 8 . Conclusions Functionalization of NOTI at the non-coordinating NH atoms of the imidazole residues for bioconjugation was straightforward and allowed the preparation of a homotrimeric RGD conjugate. After optimization of the synthesis, required building blocks to make NOTI-TVA 6 are now available on multi-gram scale. Modifications at the imidazole groups had no measurable impact on metal binding properties in vitro and in vivo suggesting that the NOTI scaffold is a promising candidate for the development of 64 Cu-labeled multimeric/multifunctional radiotracers." @default.
• W3082181797 created "2020-09-08" @default.
• W3082181797 creator A5014626023 @default.
• W3082181797 creator A5015741098 @default.
• W3082181797 creator A5031754101 @default.
• W3082181797 creator A5051737896 @default.
• W3082181797 creator A5068245115 @default.
• W3082181797 creator A5079714111 @default.
• W3082181797 creator A5082113605 @default.
• W3082181797 creator A5083810061 @default.
• W3082181797 date "2020-08-27" @default.
• W3082181797 modified "2023-10-16" @default.
• W3082181797 title "Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates" @default.
• W3082181797 cites W1600667496 @default.
• W3082181797 cites W1953582904 @default.
• W3082181797 cites W1966813721 @default.
• W3082181797 cites W1992571678 @default.
• W3082181797 cites W1993488012 @default.
• W3082181797 cites W2000171543 @default.
• W3082181797 cites W2000799481 @default.
• W3082181797 cites W2004182520 @default.
• W3082181797 cites W2007107550 @default.
• W3082181797 cites W2009510043 @default.
• W3082181797 cites W2011987037 @default.
• W3082181797 cites W2014192466 @default.
• W3082181797 cites W2015950132 @default.
• W3082181797 cites W2016918536 @default.
• W3082181797 cites W2028459481 @default.
• W3082181797 cites W2035419452 @default.
• W3082181797 cites W2048598450 @default.
• W3082181797 cites W2049886572 @default.
• W3082181797 cites W2056985174 @default.
• W3082181797 cites W2083916521 @default.
• W3082181797 cites W2094348788 @default.
• W3082181797 cites W2108021322 @default.
• W3082181797 cites W2108713158 @default.
• W3082181797 cites W2120646188 @default.
• W3082181797 cites W2121521155 @default.
• W3082181797 cites W2127625977 @default.
• W3082181797 cites W2137277859 @default.
• W3082181797 cites W2138073017 @default.
• W3082181797 cites W2146107490 @default.
• W3082181797 cites W2163316860 @default.
• W3082181797 cites W2216075799 @default.
• W3082181797 cites W2515386920 @default.
• W3082181797 cites W2606100543 @default.
• W3082181797 cites W2737434864 @default.
• W3082181797 cites W2772848330 @default.
• W3082181797 cites W2791608308 @default.
• W3082181797 cites W2796311169 @default.
• W3082181797 cites W2806658120 @default.
• W3082181797 cites W2888074429 @default.
• W3082181797 cites W2891622714 @default.
• W3082181797 cites W2894096031 @default.
• W3082181797 cites W2920957991 @default.
• W3082181797 doi "https://doi.org/10.1007/s11307-020-01530-8" @default.
• W3082181797 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7782405" @default.
• W3082181797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32856224" @default.
• W3082181797 hasPublicationYear "2020" @default.
• W3082181797 type Work @default.
• W3082181797 sameAs 3082181797 @default.
• W3082181797 citedByCount "2" @default.
• W3082181797 countsByYear W30821817972021 @default.
• W3082181797 countsByYear W30821817972023 @default.
• W3082181797 crossrefType "journal-article" @default.
• W3082181797 hasAuthorship W3082181797A5014626023 @default.
• W3082181797 hasAuthorship W3082181797A5015741098 @default.
• W3082181797 hasAuthorship W3082181797A5031754101 @default.
• W3082181797 hasAuthorship W3082181797A5051737896 @default.
• W3082181797 hasAuthorship W3082181797A5068245115 @default.
• W3082181797 hasAuthorship W3082181797A5079714111 @default.
• W3082181797 hasAuthorship W3082181797A5082113605 @default.
• W3082181797 hasAuthorship W3082181797A5083810061 @default.
• W3082181797 hasBestOaLocation W30821817971 @default.
• W3082181797 hasConcept C112613896 @default.
• W3082181797 hasConcept C166940927 @default.
• W3082181797 hasConcept C170493617 @default.
• W3082181797 hasConcept C178790620 @default.
• W3082181797 hasConcept C185592680 @default.
• W3082181797 hasConcept C195687474 @default.
• W3082181797 hasConcept C197404232 @default.
• W3082181797 hasConcept C21951064 @default.
• W3082181797 hasConcept C23963754 @default.
• W3082181797 hasConcept C2776403692 @default.
• W3082181797 hasConcept C2779281246 @default.
• W3082181797 hasConcept C2779546866 @default.
• W3082181797 hasConcept C521977710 @default.
• W3082181797 hasConcept C55493867 @default.
• W3082181797 hasConcept C71240020 @default.
• W3082181797 hasConceptScore W3082181797C112613896 @default.
• W3082181797 hasConceptScore W3082181797C166940927 @default.
• W3082181797 hasConceptScore W3082181797C170493617 @default.
• W3082181797 hasConceptScore W3082181797C178790620 @default.
• W3082181797 hasConceptScore W3082181797C185592680 @default.
• W3082181797 hasConceptScore W3082181797C195687474 @default.
• W3082181797 hasConceptScore W3082181797C197404232 @default.
• W3082181797 hasConceptScore W3082181797C21951064 @default.
• W3082181797 hasConceptScore W3082181797C23963754 @default.

• next